Dysregulated CYP1A2 expression has been associated with the onset of various human cancers, including hepatocellular carcinoma, breast cancer, prostate cancer, bladder cancer, and endometrial tumors [13]. This evidence concerns the gene CYP1A2 and urinary bladder cancer.